Wednesday 5 March 2014

Availability of stem cells improved

Long ago, stem cells successfully used to treat leukemia and other similar diseases of the hematopoietic system. However, there is a problem here: the availability of the valuable stem cells viz. To lymphoma or leukemia sufferers often wait months on, transplants, some in vain even. And that, even with umbilical cord blood in addition to bone marrow another "source for obtaining" of stem cells is available. So-called stem cell banks, stem cells cryopreserved preserve any case, this refers to the storage of cells by freezing in liquid nitrogen.


From the umbilical cord blood collection to cryopreserved stem cell: quality criteria and information
  • Documents for umbilical cord blood for accreditation should be with the help of midwives and doctors practice designed according to international standards
  • The collaboration with midwives and doctors should be continuously improved through regular audits in the removal clinics
  • The transportation of the cord blood batches should be completed within 24 hours
  • The processing is to take place in the laboratory as soon as possible in order to ensure optimum viability of the stem cells
  • Similarly, a complete temperature monitoring of all processes between the withdrawal of the cord blood for cryopreservation of stem cells to ensure
  • Application should be made only from a fixed volume of the umbilical cord removal in order to guarantee the future medical use can
  • Continuous monitoring of quality standards and latest technical standards for the isolation of stem cells in a closed system
  • Special cell biological analysis, and the detailed documentation for the characterization of stem cell batches
  • HLA typing of the batches after allogeneic cord EFI guidelines for inclusion in the international availability register
  • Ensuring adequate security - from the labs to alert security to guarantee continuous freezing of banked cord blood and disaster relief.

No comments:

Post a Comment